Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 50090-6752

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 50090-6752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lisinopril)

Chemical Structure (Lisinopril)
Chemical structure diagram of the active ingredients Lisinopril and Hydrochlorothiazide, showing multiple rings and functional groups including carboxyl, amine, and hydration components. The image highlights the molecular arrangement typical for these compounds in the tablet form.*
FDA Label Image

Chemical Structure (HCTZ)

Chemical Structure (HCTZ)
Chemical structure of the active ingredient, Lisinopril and Hydrochlorothiazide Tablets, shown as a molecular diagram highlighting key functional groups and connectivity.*
FDA Label Image

Label Image (Lbl500906752)

Label Image (Lbl500906752)
Lisinopril and Hydrochlorothiazide Tablets 20 mg/12.5 mg oral tablet bottle label from A-S Medication Solutions. The label indicates the product contains 90 tablets, storage instructions (store at 20 to 77 degrees F, protect from excessive light and humidity), and includes the lot number and NDC 50090-6752-0. The labeler address is Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.